Global Gastrointestinal Endoscopy Devices Market 2026 – 2035

The market size of the global gastrointestinal endoscopy devices will be estimated at USD 11.6 billion in 2025 and is expected to grow between USD 12.2 billion in 2026 and about USD 19.6 billion by 2035 with a current CAGR of 5.4% during the period of 2026 to 2035.

The global market for gastrointestinal endoscopy devices is experiencing a steady rise and the major factors behind this trend are the increase in the incidence of GI disorders needing endoscopy and the worldwide acceptance of screening as a precautionary measure. Ageing is one of the main reasons for the increased need for diagnostics and therapeutics through endoscopy in the developed world while the provision of medical services and facilities in developing regions, particularly in Asia Pacific, is also playing a part in the rising number of procedures.

Market Highlight

• North America had a market share of 38% and was the market leader in the gastrointestinal endoscopy devices market in 2025.

• The Asia Pacific is expected to grow at the highest CAGR during the years 2026-2035.

• By type, the flexible gastrointestinal endoscopes segment held the largest market share of over 50% in 2025.

• By end use, the outpatient facilities segment captures the largest market share of over 52% in 2025.

Significant Growth Factors

The gastrointestinal endoscopy devices market trends present significant growth opportunities due to several factors:

• Rising Prevalence of GI Diseases & Cancer Screening Programs: Amongst the factors that have propelled the gastrointestinal endoscopy devices market, the major one has been the increasing prevalence of gastrointestinal (GI) diseases. The changing landscapes of cancer screening programs have taken a major share of the market, as endoscopy still rules the game when it comes to diagnosing and delicately treating GI disorders. The increased number of these diseases, such as colorectal cancer, gastric cancer, inflammatory bowel disease, Barrett’s esophagus, and gastrointestinal bleeding, has contributed to a great extent to the demand for both diagnostic and therapeutic endoscopic procedures. The colorectal cancer screening campaigns that are supported by both governments and health organizations mainly in North America, Europe, and parts of the Asia Pacific region, are not only increasing the number of routine colonoscopies and upper GI endoscopies but also facilitating the occurrence of more repeat examinations. The early detection that screening programs provide brings about the improvement in survival rates and consequently the adoption of advanced endoscopy devices for polyp detection, biopsy, and minimally invasive treatment. This in turn leads to continuous demand for endoscopes, visualization systems and related accessories. Patients and providers alike have become more aware of the importance of preventive healthcare and screening; thus, they are willing to undergo screening procedures regardless of the potential drawbacks. Consequently, health care institutions are significantly increasing their investments in modern GI endoscopy equipment, which is a strong factor for the constant growth of the market. For instance, the United European Gastroenterology (UEG) report mentions a total of around 332 million individuals in the European region with a forecast incidence of digestive disorders.

• Shift Toward Minimally Invasive Therapy: The gastrointestinal endoscopy devices market is primarily being pushed forward by the adoption of minimally invasive therapy as a major trend. This is because doctors are opting for endoscopic procedures significantly more often than traditional and laparoscopic surgeries due to the fact that patient trauma is minimal as well as hospital stays are shorter, recovery times are quicker, and overall healthcare costs are reduced. Nowadays, gastrointestinal endoscopy is not only used for diagnosis but also for various therapeutic interventions that include but are not limited to, polyp removal, endoscopic mucosal resection (EMR), endoscopic submucosal dissection (ESD), hemostasis, dilation, and stent placement. The developments in endoscopic instruments, imaging technology, and supporting devices have increased the number and difficulty of interventions that can be performed through non-invasive techniques safely, thereby making endoscopy the primary treatment option for many gastrointestinal problems. The healthcare sectors are concentrating on the enhancement of clinical outcomes and, at the same time, minimizing risks associated with the procedures as well as the burden of hospitalization. The upward trend in the use of minimally invasive endoscopic therapies therefore, continues to bolster the demand for advanced gastrointestinal endoscopy devices in both hospitals and outpatient surgical centers.

What are the Major Advances Changing the Gastrointestinal Endoscopy Devices Market Today?

• High-Definition (HD), 4K & Image-Enhanced Endoscopy: High-Definition (HD), 4K, and image-enhanced endoscopy are among the essential technological innovations affecting the development of the gastrointestinal endoscopy devices market since they drastically improve visualization, diagnostic accuracy, and clinician confidence. The highest resolution, color contrast, and depth perception are the features of these advanced imaging systems, and thus, they enable the doctors to spot even the smallest mucosal irregularities, tumors of the very first stage, and flat or small lesions that are usually ignored with standard-definition endoscopes. Besides, the use of new concepts like narrow-band imaging (NBI), blue-light imaging (BLI), and linked color imaging (LCI) has made the diagnosis of cancers and inflammatory conditions much faster and more accurate, as these technologies increase recognition of the blood vessels and the surface patterns. The hospitals and clinics are thus forced to strengthen their detection of lesions, raise their adenoma detection rates, and lower their miss rates, which are the clinical benefits of using such a modern device, which in turn drives the demand for system upgrades and thus goes on to sustain the market growth. For instance, in July 2025, FUJIFILM (Thailand) Ltd. remains at the forefront of healthcare diagnostics and patient treatment with its innovative health revolution, and the ELUXEO® 8000 Endoscopy System and the 800 Series ELUXEO® Endoscopes are the latest additions to its product line that are introduced to Thailand. The ELUXEO® 8000 Endoscopy System sets a new bar in the accuracy of gastrointestinal and liver endoscopy by introducing a new ACI (Amber-Red Color Imaging) mode that drastically enhances the safety of the procedure. The ELUXEO® 8000 Endoscopy System offers Fujifilm's ultimate image quality by merging technologies of X-ray and ultrasound departments with Triple Noise Reduction (3NR) technology from imaging technology groups, along with Extended Dynamic Range. This results in high-quality images with uniform brightness in both close and distant areas. The new system increases image quality from FHD to 4K Ultra HD, resulting in greatly improved clarity that allows doctors to detect lesions and abnormalities with an accuracy that is unbelievably high.

• Expansion of Therapeutic Endoscopy: Therapeutic endoscopy is considered a major technological breakthrough in the gastrointestinal endoscopy devices market since the endoscopy is now widely accepted not only for the diagnosis but also for the definitive treatment of several gastrointestinal disorders. Apart from that, advanced endoscopic techniques like EMR and ESD allow for the minimally invasive removal of very early-stage tumors and even precancerous masses, thus lowering the requirement for open or laparoscopic surgeries. Therapeutic endoscopy is extensively accepted even for such procedures as endoscopic hemostasis, dilation, polypectomy, and gastrointestinal stent placement due to the advantages of faster recovery, lower complication rates, and shorter hospital stays. The constant improvements in endoscopic accessories, energy devices, and visualization systems have been the main factor in the increased complexity and success of these interventions. As healthcare providers progressively focus on the minimally invasive, cost-effective treatments that have strong clinical outcomes, the growing range of therapeutic endoscopy continues to drive the demand for sophisticated gastrointestinal endoscopy devices in the hospitals and ambulatory surgical centers.

Category Wise Insights

By Type

Why Flexible Gastrointestinal Endoscopes Lead the Market?

The flexible gastrointestinal endoscopes segment held the largest market share of over 50% in 2025 owing to its favorable properties. The major advantages of utilizing flexible gastrointestinal endoscopes are the patient's comfort, which is greatly improved due to the reduced invasiveness and the little trauma that is caused during the procedure in comparison to rigid alternatives, thus letting a minority of the procedures be done on an outpatient basis. Their ability to maneuver in a better way helped to reach the difficult anatomical regions, which has increased diagnostic accuracy and procedural success rates. The use of flexible endoscopes helped all medical interventions to be performed easily and with less complication of open surgery and thus, recovering in a shorter time. Besides, the high-definition imaging and image-enhancement technologies that have been advanced and integrated into flexible endoscopes have not only improved the lesion detection but also the clinical decision-making, thus making them a vital driver of efficiency, cost-effectiveness, and enhanced outcomes in gastrointestinal care.

The disposable gastrointestinal endoscopes segment is growing at the highest CAGR of 7.6% over the projected period. The increase in sales is attributed to the rising worries regarding infection control and patient safety. Disposable devices are considered the safest option in hospitals and clinics since they prevent any possibility of virus and bacteria sharing. Besides, the easy handling along with the lesser need for sterilization is also a factor contributing to their preference.

By End Use

Why Outpatient Facilities Dominates the Gastrointestinal Endoscopy Devices Market?

The outpatient facilities segment captures the largest market share of over 52% in 2025. The rise is attributed to the preference for minimally invasive techniques that enable patients to have diagnoses and treatments done without staying in the hospital for long. This move has made it easier for patients, reduced the cost of healthcare, and made endoscopic interventions in outpatient settings more popular.

The hospitals segment is expected to grow at the highest rate over the projected period. This is primarily due to the tremendous skills of the hospitals in treating critical cases and emergencies. The hospitals equipped with the latest technology and staffed with the most qualified professionals can perform a wide range of diagnostic and therapeutic procedures, which consequently requires the use of advanced endoscopic devices for different GI problems to be treated effectively.

Report Scope

Regional Analysis

How Big is the North America Gastrointestinal Endoscopy Devices Market Size?

Its market size, in terms of North America gastrointestinal endoscopy devices, is projected to be USD 4.4 billion in 2025 with a growth of about USD 7.2 billion in 2035 with a CAGR of 5.0% between 2026 and 2035.

Why did North America Dominate the Gastrointestinal Endoscopy Devices Market in 2025?

In 2025, North America will dominate the global market with an estimated market share of 38%. The area gets a positive impact from a well-established network of hospitals and surgical centers, where the use of flexible endoscopes is preferred mainly because of their versatility, comfort to patients, and applicability to minimally invasive outpatient procedures. Each of these factors has a great impact on the North American market for flexible gastrointestinal endoscopes which is a leading and regularly increasing market. The reimbursement systems are also very advantageous, and there is a high level of medical care spending along with a greater awareness of preventive healthcare which all together makes the healthcare professionals to opt for technologically advanced flexible GI endoscopy systems.

U.S. Gastrointestinal Endoscopy Devices Market Trends

In the North American region, the US leads the industry expansion over the projected period. Aging population and a significant rise in chronic diseases, especially gastrointestinal disorders are the main characteristics of the country. The increase in the demand for minimally invasive operations and the ongoing improvements in endoscopic techniques are making diagnosis and treatment much better, thereby pushing the market forward.

Why is Asia Pacific Experiencing the Fastest Growth in the Gastrointestinal Endoscopy Devices Market?

Asia Pacific is growing at the highest CAGR over the analysis period. The market's expansion is primarily the result of government-initiated screening programs, particularly in gastric and colorectal cancers, along with increased investments in public and private healthcare facilities in the area. The establishment of new hospitals and ambulatory endoscopy centers, along with the better availability of trained gastroenterologists, is drawing the use of flexible endoscopes faster. Moreover, the demand for affordable and technologically advanced flexible endoscopy systems with high-definition imaging and minimally invasive therapeutic capabilities is rising in the Asia Pacific region as the medical professionals are looking to achieve better clinical outcomes even under a large patient load. The region’s medical tourism, young population, and gradually improving reimbursement and healthcare expenditure combined have made Asia Pacific one of the fastest-growing markets for gastrointestinal endoscopes.

India Gastrointestinal Endoscopy Devices Market Trends

India is growing at the fastest rate of over 5.0% market CAGR. The market growth is driven by the rise in investments in healthcare infrastructure, the increased awareness of preventive health measures, and government programs aimed at making diagnostic services more accessible.

Why is Europe is growing at a significant rate in the Gastrointestinal Endoscopy Devices Market?

Europe holds the substantial market share over the projected period. The market is positively influenced by the region's emphasis on cutting-edge medical technologies and well-established healthcare systems. This is mainly due to factors like increased awareness about gut health, more cases of colorectal cancer, and favorable health insurance policies encouraging early detection.

Germany Gastrointestinal Endoscopy Devices Market Trends

Germany holds the dominant position in the Europe market. The strong healthcare infrastructure, the considerable investment in medical technology, and the sizeable presence of qualified healthcare staff are the main factors supporting the market. Moreover, the rising cases of gastrointestinal diseases in the population and the preventive-care-oriented strategy are major factors contributing to the endoscopic devices market.

Why is the Middle East & Africa Region is growing rapidly in the Gastrointestinal Endoscopy Devices?

The MEA region is growing at a steady rate over the projected period. MEA is backed by the increase of private healthcare facilities, the development of medical tourism, and the increasing use of minimally invasive procedures that lead to shorter hospital stays and lower overall treatment costs.

Saudi Arabia Gastrointestinal Endoscopy Devices Market Trends

Saudi Arabia is growing at the highest CAGR during the forecast period. The growth is owing to the increasing government investment in the area.

Top Players in the Gastrointestinal Endoscopy Devices Market and Their Offerings

• HOYA Corporation (PENTAX Medical)

• Boston Scientific Corporation

• Fujifilm Holdings Corporation

• Johnson & Johnson Services Inc. (Ethicon Inc.)

• KARL STORZ SE & Co. KG

• Medtronic

• Stryker

• Olympus Corporation

• Smith+Nephew

• Cook

• CONMED Corporation

• Ambu A/S

• Richard Wolf GmbH

• STERIS plc

• Others

Key Developments

Gastrointestinal endoscopy devices market has experienced considerable changes in the last two years as the market players are trying to diversify their technological aspects and develop product portfolios using strategic approaches.

• In October 2025, The Hepatogastroentrology Endoscopy Unit, which is a very important part of TBRI's development plan for the institution, where the quality of medical and research services is the main target, has been upgraded and modernized by the Theodor Bilharz Research Institute TBRI to a significant extent. The qualitative jump would have never been achieved without the input of the Institute's director and the chairman of the board, Prof. Dr. Ahmed Abdel Aziz. The partnership between the Institute and the Scope Medical Company has resulted in obtaining a set of endoscopy instruments that are among the most advanced globally. This event is not only a sign of the Institute's desire to keep up with scientific and technological progress in the different medical fields but also an expression of its commitment to quality and precision in patient treatment through the improvement of its clinical units. (https://www.tbri.sci.eg/en/institute-news/tbri-enhances-its-capabilities-with-the-latest-gastrointestinal-endoscopy-equipment-under-a-cooperation-protocol-with-scope-medical)

These strategic measures have enabled the companies to reinforce their competitive positions, increase the product line, boost their technological competencies and also seize growth opportunities in the fast-growing gastrointestinal endoscopy devices market.

The Gastrointestinal Endoscopy Devices Market is segmented as follows:

By Type

• Rigid Gastrointestinal Endoscopes

• Flexible Gastrointestinal Endoscopes

• Disposable Gastrointestinal Endoscopes

By End Use

• Hospitals

• Outpatient Facilities

Regional Coverage:

North America

• U.S.

• Canada

• Mexico

• Rest of North America 

Europe

• Germany

• France

• U.K.

• Russia

• Italy

• Spain

• Netherlands

• Rest of Europe

Asia Pacific

• China

• Japan

• India

• New Zealand

• Australia

• South Korea

• Taiwan

• Rest of Asia Pacific 

The Middle East & Africa

• Saudi Arabia

• UAE

• Egypt

• Kuwait

• South Africa

• Rest of the Middle East & Africa

Latin America

• Brazil

• Argentina

• Rest of Latin America